Skip to main content
. 2022 Jan 24;22:35. doi: 10.1186/s12883-022-02560-1

Fig. 1.

Fig. 1

Measures of clinical burden in 5–2-1-positive patients compared with 5–2-1-negative patients. *p < 0.0001. 5–2-1, taking ≥5 doses of oral levodopa/day, OR having ≥2 h ‘off’-time/waking day, OR having ≥1 h troublesome dyskinesia/waking day. ADL, activities of daily living; MMSE, Mini-Mental State Examination; PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating Scale